ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Vivanza Biosciences declared that its statutory auditors issued an audit report with an unmodified opinion. This covers results for the quarter and year ended March 31, 2026.
Vivanza Biosciences confirmed non-applicability of SEBI's Related Party Transaction disclosures for March 2026. The company remains below regulatory thresholds for mandatory reporting.
Vivanza Biosciences Ltd announced the non-applicability of the Annual Secretarial Compliance Report for the year ended March 31, 2026. The company is exempt under SEBI Regulation 15(2) as its paid-up capital is ₹4 Crore and net worth is approximately ₹4.02 Crore, both falling below the mandatory reporting thresholds.